3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Lymphoma, AIDS-Related
1
HIV Infections
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Doxorubicin
8
Vincristine
7
Etoposide
7
Cyclophosphamide
7
Rituximab
5
Prednisone
5
Filgrastim
5
Zidovudine
3
Bleomycin
3
Vinblastine
2
Thalidomide
2
Paclitaxel
2
Mitoxantrone
2
Interferon-alpha
2
Interferon alpha-2
2
Dacarbazine
2
Cytarabine
2
Cisplatin
2
ziconotide
1
vesnarinone
1
tin etiopurpurin
1
nirogacestat
1
liposomal doxorubicin
1
interferon gamma-1b
1
fludarabine phosphate
1
fludarabine
1
efavirenz
1
dehydroftorafur
1
Whole-Body Irradiation
1
Valganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
HIV Infections
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled